Clinical trial
PROMPT - Palifermin in Reduction of Oral Mucositis in PBSC Transplantation
NCT00352703 · Swedish Orphan Biovitrum, Industry · Completed
Key facts
| NCT number | NCT00352703 |
|---|---|
| Title | PROMPT - Palifermin in Reduction of Oral Mucositis in PBSC Transplantation |
| Official title | An Open-label, Single-arm Study of Palifermin for Reduction of Mucositis in Subjects With Non-Hodgkin's Lymphoma or Multiple Myeloma Undergoing High-Dose Chemotherapy and Autologous Peripheral Blood Stem Cell (PBSC) Transplantation |
| Lead sponsor | Swedish Orphan Biovitrum, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Non-Hodgkin's Lymphoma, Multiple Myeloma |
| Intervention type | Drug |
| Interventions | Kepivance (Palifermin) |
| Enrollment | 145 |
| Start date | Apr 1, 2006 |
| Primary completion | Apr 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Jul 17, 2006 |
| Last update posted | Nov 3, 2014 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: